Mark William Lowdell - 03 Nov 2021 Form 4 Insider Report for Inmune Bio, Inc. (INMB)

Role
Chief Scientific Officer, 10%+ Owner
Signature
/s/ Mark William Lowdell
Issuer symbol
INMB
Transactions as of
03 Nov 2021
Net transactions value
-$14,020
Form type
4
Filing time
04 Nov 2021, 16:00:47 UTC
Previous filing
29 Oct 2021
Next filing
23 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INMB Common Stock Sale $14,020 -701 -0.05% $20.00 1,472,793 03 Nov 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.